Increased interleukin‐6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia
- 1 April 1998
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 28 (4) , 491-496
- https://doi.org/10.1046/j.1365-2222.1998.00268.x
Abstract
Background: The Gleich syndrome is rare and associates recurrent angioedema, urticaria, fever, weight gain and blood hypereosinophilia, underlying systemic and local inflammation. The pathogenesis of those symptoms remains unclear.Objective: We wanted to address the possible implication of Interleukin‐6 (IL‐6) in the development of those clinical features, and to identify the cells involved in its production.Methods: A 26‐year‐old man suffering of this disease was referred in hospital. During an acute attack with weight gain, fever and a diffuse oedema, a marked increase in eosinophils count (42700/mm3 was observed. Serum ECP was elevated at 47 μg/L (normal less than 16). Corticosteroid therapy administrated on the 7th day was followed by a rapid remission. Blood samples were collected (before, during the attack and under corticosteroid therapy) for measurements of serum IL‐6 (ELISA, Immunotech, Marseille, France) and plasma histamine (RIA, Immunotech, Marseille, France). Blood monocytes and eosinophils were isolated and a skin biopsy was performed during the attack.Results: The plasma histamine level was within normal range. The level of IL‐6 in sera peaked to 74 pg/mL, concomitant with the peak of eosinophilia at the acute phase phase of the attack. Under corticosteroids, we observed a drop in the IL‐6 serum level to 29 pg/mL, concomitant with the clinical remission. During the attack, an increase in IL‐6 production was observed in 24 h blood monocyte supernatants (11.103 pg/mL compared with 2.4 ± 0.8.103 pg/mL for BM from controls) as well as in skin endothelial cells but not in the blood and skin eosinophils. In vitro, when endothelial cells were incubated in eosinophils supernatants of the patient, liberation of IL‐6 was observed (3.3 103 pg/mL compared with controls: 2.1 103 pg/mL)Conclusion: Serum IL‐6 elevation may be related to an increased production by blood monocytes and endothelial cells, possibly stimulated by eosinophil mediator during the acute phase of the disease, and might participate in the inflammatory reaction of this syndrome.Keywords
This publication has 19 references indexed in Scilit:
- Increased interleukin 6, but reduced interleukin 1, in delayed pressure urticariaBritish Journal of Dermatology, 1993
- Role of Microvascular Endothelial Cells in InflammationJournal of Investigative Dermatology, 1993
- Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 proteinJournal of Allergy and Clinical Immunology, 1992
- Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individualsJournal of Allergy and Clinical Immunology, 1992
- Biological and clinical aspects of interleukin 6Immunology Today, 1990
- Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophiliaClinical and Experimental Immunology, 1990
- Episodic angioedema with eosinophiliaJournal of the American Academy of Dermatology, 1989
- B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes.The Journal of Experimental Medicine, 1988
- Episodic Angioedema Associated with EosinophiliaNew England Journal of Medicine, 1984
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973